Hotgen Coronavirus Antigen Test Has Passed British 3A Validation, Monkeypox Virus Nucleic Acid IVD Kit Has Obtained British MHRA

Recently, Hotgen Coronavirus (2019-nCoV)-Antigentest has officially passed 3a validation of the UK Department of Health and Social Care (DHSC), which proves that the antigen test not only has high specificity, but also has high detection sensitivity.

At present, the COVID-19 epidemic is still spreading in countries around the world. The latest data from the WHO shows that the number of confirmed cases in the world has exceeded 550 million. Under the rapid spread of the COVID-19 epidemic, self-testing is becoming more and more popular. Hotgen coronavirus antigen test is easy to operate and fast to detect. It has passed many global mainstream registration such as the EU CE, Germany (BfArM), France (ANSM), Singapore Health Sciences Authority (HSA), Brazil Health Authority (ANVISA), etc. For the record, it has been exported to nearly 40 countries and regions around the world such as Germany, France, Italy, Austria, Hong Kong, Singapore, Vietnam, Thailand, Brazil, Peru, etc., and has become a mainstream product in European self-testing market.

Hotgen Coronavirus (2019-nCoV)-Antigentest-Components

In addition, Hotgen monkeypox virus nucleic acid IVD kit (PCR-fluorescent probe method) has completed the MHRA registration in the UK and can now be sold to the UK.

To develop biotechnology for the benefit of human health，Hotgen will not forget our original intention, forge ahead and give full play to the value of our products, and provide more assistance for the international fight against the COVID-19 epidemic.